EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

MD

Manufacturing and distribution of biodefense vaccines & therapeutics & cancer drug R&D

Filings
36
Firms Hired
1
Total Expenses
—
Years Active
2007–2016

Filings

All 2016201520142013201220112010200920082007
YearFirmPeriodExpensesDoc
2016 DALRYMPLE & ASSOCIATES, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination 		—
2015 DALRYMPLE & ASSOCIATES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2015 DALRYMPLE & ASSOCIATES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2015 DALRYMPLE & ASSOCIATES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2015 DALRYMPLE & ASSOCIATES, LLC 1st Quarter (Jan 1 - Mar 31)
AMENDED 		—
2014 DALRYMPLE & ASSOCIATES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2014 DALRYMPLE & ASSOCIATES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2014 DALRYMPLE & ASSOCIATES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2014 DALRYMPLE & ASSOCIATES, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2013 DALRYMPLE & ASSOCIATES, LLC 4th Quarter (Oct 1 - Dec 31)
AMENDED 		—
Page 1 of 4  ·  36 filings Next
Firms Hired
FirmFilingsExpenses
DALRYMPLE & ASSOCIATES, LLC 36 —
Issue Areas
IssueActivities
Defense 36
Homeland Security 35
Medical/Disease Research/Clinical Labs 32
Health Issues 4
Budget/Appropriations 1

Bills Mentioned in Filings

S.1915 HR 3299 HR1300